MMP2 and neoplasm: In this work we aim to test the potential use of the MMP‐2/‐9 activatable CPPs for antitumor therapy upon systemic administration of the nanoparticles consisting of CPPs and plasmid DNA (pDNA) that expresses short hairpin RNA against VEGF (shVEGF) to tumor‐bearing mice.